Avila Therapeutics Inc.
Formerly Conxcys, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Avila Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2010).
SEC Form D · Jul 2010
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2010
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Avila Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Katrine Bosley | Executive officer | Jul 2010 |
| Michael F. Bigham | Executive officer | Jul 2010 |
| Roy R. Lobb | Executive officer | Jul 2010 |
| Daniel Lynch | Executive officer | Jul 2009 |
| Amir R. Nashat | Director | Jul 2010 |
| Bruce F. Booth | Director | Jul 2010 |
| Daniel R. Lynch | Director | Jul 2010 |
| Henry R. Skinner | Director | Jul 2010 |
| Katrine Bosley | Director | Jul 2010 |
| Michael F. Bigham | Director | Jul 2010 |
| Raj R. Parekh | Director | Jul 2010 |
| Roy R. Lobb | Director | Jul 2010 |
| Vicki R. Sato | Director | Jul 2010 |
| Amir Nashat | Director | Jul 2009 |
| Bruce Booth | Director | Jul 2009 |
| Daniel Lynch | Director | Jul 2009 |
| Henry Skinner | Director | Jul 2009 |
| Raj Parekh | Director | Jul 2009 |
| Vicki Sato | Director | Jul 2009 |